May 2022
Sale of GeneDx, Inc., a Subsidiary of OPKO Health, Inc. (NASDAQ: OPK) to Sema4 Holdings Corp. (SMFR)
Financial Advisor
View DetailsApr 2022
$225 Million
Transactions
Our primary goals as an organization are achieved through adhering to our core values of vision, empathy, sustainability and tenacious teamwork in pursuit of our clients’ interests.
